Your browser doesn't support javascript.
loading
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.
Tomaschitz, Andreas; Verheyen, Nicolas; Meinitzer, Andreas; Pieske, Burkert; Belyavskiy, Evgeny; Brussee, Helmut; Haas, Josef; März, Winfried; Pieske-Kraigher, Elisabeth; Verheyen, Sarah; Ofner-Ziegenfuss, Lisa; Hartaigh, Bríain Ó; Schwetz, Verena; Aberer, Felix; Grübler, Martin; Lang, Florian; Alesutan, Ioana; Voelkl, Jakob; Gaksch, Martin; Horina, Jörg H; Dimai, Hans-Peter; Rus-Machan, Jutta; Stiegler, Claudia; Ritz, Eberhard; Fahrleitner-Pammer, Astrid; Pilz, Stefan.
Affiliation
  • Tomaschitz A; aSpecialist Clinic for Rehabilitation Bad Aussee, Bad Aussee bDepartment of Cardiology cClinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria dDepartment of Internal Medicine - Cardiology, Charité University Hospital Berlin, Campus Virchow Klinikum eDeutsches Herzzentrum, Berlin, Germany fDepartment of Obstetrics and Gynaecology, Medical University of Graz, Graz, Austria gSynlab Academy, Synlab Services LLC, Mannheim hVth Department of Medic
J Hypertens ; 34(7): 1347-56, 2016 07.
Article in En | MEDLINE | ID: mdl-27065001

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parathyroid Hormone / Spironolactone / Blood Pressure / Mineralocorticoid Receptor Antagonists / Hyperparathyroidism, Primary Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Hypertens Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parathyroid Hormone / Spironolactone / Blood Pressure / Mineralocorticoid Receptor Antagonists / Hyperparathyroidism, Primary Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Hypertens Year: 2016 Document type: Article